Compare Immunovant Inc. Common Stock (IMVT) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Star Bulk Carriers Corp — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Star Bulk Carriers Corp trades at $30.36 (market cap $3.45B). The key difference: Immunovant Inc. Common Stock is the larger of the two by market cap, and Star Bulk Carriers Corp pays a 6.33% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Star Bulk Carriers Corp for 24 Days on average.
| IMVT | SBLK | |
|---|---|---|
Market Cap | $6.62B | $3.45B |
Volume | 1,131,364 | 1,355,871 |
Sector | Health | Industrials |
52-Week High | $44.96 | $32.49 |
52-Week Low | $17.03 | $16.79 |
Typical Hold Time | 0 Days | 24 Days |
Enterprise Value | $5.72B | $4.13B |
Dividend Yield | — | 6.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Star Bulk Carriers (SBLK) trades at $29.69, down 0.57% on the day, with a bearish technical signal from moving averages but neutral oscillators. Fundamentally, the company shows strong profitability with a 23.87% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights insider buying and a declared $0.90 dividend for H2 2026, reflecting management confidence.
The outlook is positive given robust earnings performance and attractive valuation multiples, though near-term technical weakness and reliance on shipping market cycles pose risks. Analyst consensus is bullish with 14 buy ratings, supporting potential upside if operational strength continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
